229 related articles for article (PubMed ID: 10096254)
21. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
23. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
[TBL] [Abstract][Full Text] [Related]
24. CITED1 expression in Wilms' tumor and embryonic kidney.
Lovvorn HN; Westrup J; Opperman S; Boyle S; Shi G; Anderson J; Perlman EJ; Perantoni AO; Wills M; de Caestecker M
Neoplasia; 2007 Jul; 9(7):589-600. PubMed ID: 17710162
[TBL] [Abstract][Full Text] [Related]
25. [Nephroblastomas (Wilms' tumors) and special variations of nephroblastomas].
Schmidt D
Veroff Pathol; 1989; 133():1-174. PubMed ID: 2556868
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5.
Oue T; Koshinaga T; Takimoto T; Okita H; Tanaka Y; Nozaki M; Haruta M; Kaneko Y; Fukuzawa M;
Pediatr Surg Int; 2016 Sep; 32(9):851-5. PubMed ID: 27473009
[TBL] [Abstract][Full Text] [Related]
27. Expression of MIB and BCL-2 in patients with nephrogenic rests with and without associated Wilms' tumors.
Wünsch L; Flemming P; Glüer S
Eur J Pediatr Surg; 2001 Apr; 11(2):105-9. PubMed ID: 11371029
[TBL] [Abstract][Full Text] [Related]
28. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
[TBL] [Abstract][Full Text] [Related]
29. Effect of hyperthermia 42.5 degrees C/120 min on 3H-thymidine incorporation in different tissue components of Wilms' tumors: an in vitro study.
Willnow U; Dumon K; Godehardt E
Klin Padiatr; 1996; 208(4):145-50. PubMed ID: 8776702
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of the lung resistance-related protein/major vault protein in the histological compartments of nephroblastomas.
Efferth T; Bode ME; Schulten HG; Thelen P; Granzen B; Beniers AJ; Mertens R; Gefeller O; Ringert RH; Jakse G; Fuzesi L
Int J Oncol; 2001 Jul; 19(1):163-8. PubMed ID: 11408938
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
32. [Anaplastic type of Wilms' tumour].
Vujanić GM; Aleksandrović S
Srp Arh Celok Lek; 1990; 118(9-10):353-6. PubMed ID: 1966350
[TBL] [Abstract][Full Text] [Related]
33. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.
Natrajan R; Little SE; Reis-Filho JS; Hing L; Messahel B; Grundy PE; Dome JS; Schneider T; Vujanic GM; Pritchard-Jones K; Jones C
Clin Cancer Res; 2006 Dec; 12(24):7284-93. PubMed ID: 17189400
[TBL] [Abstract][Full Text] [Related]
34. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations.
Bardeesy N; Falkoff D; Petruzzi MJ; Nowak N; Zabel B; Adam M; Aguiar MC; Grundy P; Shows T; Pelletier J
Nat Genet; 1994 May; 7(1):91-7. PubMed ID: 8075648
[TBL] [Abstract][Full Text] [Related]
36. novH: differential expression in developing kidney and Wilm's tumors.
Chevalier G; Yeger H; Martinerie C; Laurent M; Alami J; Schofield PN; Perbal B
Am J Pathol; 1998 Jun; 152(6):1563-75. PubMed ID: 9626060
[TBL] [Abstract][Full Text] [Related]
37. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors.
Wirths O; Waha A; Weggen S; Schirmacher P; Kühne T; Goodyer CG; Albrecht S; Von Schweinitz D; Pietsch T
Lab Invest; 2003 Mar; 83(3):429-34. PubMed ID: 12649343
[TBL] [Abstract][Full Text] [Related]
39. Differential apoptosis gene expression in pediatric tumors of the kidney.
Takamizawa S; Okamoto S; Bishop W; Wen J; Kimura K; Sandler A
J Pediatr Surg; 2000 Feb; 35(2):390-5. PubMed ID: 10693703
[TBL] [Abstract][Full Text] [Related]
40. Expression of the p53 and Wilms' tumor suppressor genes in the rat ovary: gonadotropin repression in vivo and immunohistochemical localization of nuclear p53 protein to apoptotic granulosa cells of atretic follicles.
Tilly KI; Banerjee S; Banerjee PP; Tilly JL
Endocrinology; 1995 Apr; 136(4):1394-402. PubMed ID: 7895650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
